Literature DB >> 11237815

Malaria enhances expression of CC chemokine receptor 5 on placental macrophages.

A N Tkachuk1, A M Moormann, J A Poore, R A Rochford, S W Chensue, V Mwapasa, S R Meshnick.   

Abstract

Malaria and human immunodeficiency virus (HIV) coinfections are common in pregnant women in sub-Saharan Africa. The current study shows that placentas of malaria-infected women contain 3 times as much CC chemokine receptor 5 (CCR5) RNA as placentas of women without malaria. By immunohistochemistry, CCR5(+) maternal macrophages were seen in placentas from malaria-infected women but not in placentas from malaria-uninfected women. In addition, CCR5 also was found on fetal Hofbauer cells in placentas from both groups. Thus, malaria infections increase the potential reservoir for HIV in the placenta by increasing the number of HIV target cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237815     DOI: 10.1086/319248

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

2.  Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda.

Authors:  Philip L Bulterys; Ann Chao; Sudeb C Dalai; M Christine Zink; Abel Dushimimana; David Katzenstein; Alfred J Saah; Marc Bulterys
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 3.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

4.  Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.

Authors:  Samad A Ibitokou; Lise Denoeud-Ndam; Sèm Ezinmegnon; Rodolphe Ladékpo; Djimon-Marcel Zannou; Achille Massougbodji; Pierre-Marie Girard; Michel Cot; Adrian J F Luty; Nicaise Tuikue Ndam
Journal:  Am J Trop Med Hyg       Date:  2015-06-22       Impact factor: 2.345

5.  Clinical malaria diagnosis in pregnancy in relation to early perinatal mother-to-child transmission of HIV: a prospective cohort study.

Authors:  A E Ezeamama; C Duggan; K P Manji; D Spiegelman; E Hertzmark; R J Bosch; R Kupka; J O Okuma; R Kisenge; S Aboud; W W Fawzi
Journal:  HIV Med       Date:  2013-11-11       Impact factor: 3.180

6.  Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya.

Authors:  Steven D Perrault; Jan Hajek; Kathleen Zhong; Simon O Owino; Moses Sichangi; Geoffrey Smith; Ya Ping Shi; Julie M Moore; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

7.  HIV prevalence in a gold mining camp in the Amazon region, Guyana.

Authors:  Carol J Palmer; Lloyd Validum; Bernard Loeffke; Harold E Laubach; Chris Mitchell; Rudy Cummings; Raul R Cuadrado
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 8.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

9.  Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection.

Authors:  Sujittra Chaisavaneeyakorn; Julie M Moore; Lisa Mirel; Caroline Othoro; Juliana Otieno; Sansanee C Chaiyaroj; Ya Ping Shi; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjects.

Authors:  L Nigro; M L Rizzo; C Vancheri; R La Rosa; C Mastruzzo; V Tomaselli; A Ragusa; R Manuele; B Cacopardo
Journal:  Med Microbiol Immunol       Date:  2007-04-25       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.